The c-myc-regulated microRNA-17 ̃92 (mir-17 ̃92) and miR-106a ̃363 clusters target hCYP19A1 and hGCM1 to inhibit human trophoblast differentiation

Molecular and Cellular Biology

Volumn 33, Issue 9, 2013, Pages 1782-1796

  Kumar, Premlata ^a   Luo, Yanmin ^a,c   Tudela, Carmen ^b   Alexander, James M ^b   Mendelson, Carole R ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b North Texas March of Dimes Birth Defects Center   (United States)

^c THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; CHORIONIC GONADOTROPIN BETA SUBUNIT; GLIAL CELL MISSING 1; MICRORNA; MICRORNA 106A; MICRORNA 17; MICRORNA 19B; MICRORNA 363; MICRORNA 92; MYC PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTROPHOBLAST; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROARRAY ANALYSIS; PATHOGENESIS; PLACENTA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNCYTIOTROPHOBLAST; TROPHOBLAST;

AROMATASE; BASE SEQUENCE; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MICRORNAS; NUCLEAR PROTEINS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PROTO-ONCOGENE PROTEINS C-MYC; TRANSCRIPTION FACTORS; TROPHOBLASTS;

EID: 84876454122     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01228-12     Document Type: Article

References (67)

1. Everett RB, MacDonald PC. 1979. Endocrinology of the placenta. Annu. Rev. Med. 30:473-488.
2. Genbacev O, Joslin R, Damsky CH, Polliotti BM, Fisher SJ. 1996. Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. J. Clin. Invest. 97:540-550.
3. Jiang B, Kamat A, Mendelson CR. 2000. Hypoxia prevents induction of aromatase expression in human trophoblast cells in culture: potential inhibitory role of the hypoxia-inducible transcription factor Mash-2 (mammalian achaete-scute homologous protein-2). Mol. Endocrinol. 14:1661-1673.
4. Fournet-Dulguerov N, MacLusky NJ, Leranth CZ, Todd R, Mendelson CR, Simpson ER, Naftolin F. 1987. Immunohistochemical localization of aromatase cytochrome P-450 and estradiol dehydrogenase in the syncytiotrophoblast of the human placenta. J. Clin. Endocrinol. Metab. 65:757-764.
5. Kamat A, Alcorn JL, Kunczt C, Mendelson CR. 1998. Characterization of the regulatory regions of the human aromatase (P450arom) gene involved in placenta-specific expression. Mol. Endocrinol. 12:1764-1777.
6. Rosenfeld CR, Morriss FH, Jr, Battaglia FC, Makowski EL, Meschia G. 1976. Effect of estradiol-17β on blood flow to reproductive and nonreproductive tissues in pregnant ewes. Am. J. Obstet. Gynecol. 124:618-629.
7. Jobe SO, Ramadoss J, Koch JM, Jiang Y, Zheng J, Magness RR. 2010. Estradiol-17β and its cytochrome P450- and catechol-O-methyltransferasederived metabolites stimulate proliferation in uterine artery endothelial cells: role of estrogen receptor-β versus estrogen receptor-β. Hypertension 55: 1005-1011.
8. Kanasaki K, Palmsten K, Sugimoto H, Ahmad S, Hamano Y, Xie L, Parry S, Augustin HG, Gattone VH, Folkman J, Strauss JF, Kalluri R. 2008. Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature 453:1117-1121.
9. Lee SB, Wong AP, Kanasaki K, Xu Y, Shenoy VK, McElrath TF, Whitesides GM, Kalluri R. 2010. Preeclampsia: 2-methoxyestradiol induces cytotrophoblast invasion and vascular development specifically under hypoxic conditions. Am. J. Pathol. 176:710-720.
10. Albrecht ED, Pepe GJ. 2010. Estrogen regulation of placental angiogenesis and fetal ovarian development during primate pregnancy. Int. J. Dev. Biol. 54:397-408.
11. Jiang B, Mendelson CR. 2003. USF1 and USF2 mediate inhibition of human trophoblast differentiation and CYP19 gene expression by Mash-2 and hypoxia. Mol. Cell. Biol. 23:6117-6128.
12. Jiang B, Mendelson CR. 2005. O2 enhancement of human trophoblast differentiation and hCYP19 (aromatase) gene expression are mediated by proteasomal degradation of USF1 and USF2. Mol. Cell. Biol. 25:8824-8833.
13. Petraglia F, Florio P, Nappi C, Genazzani AR. 1996. Peptide signaling in human placenta and membranes: autocrine, paracrine, and endocrine mechanisms. Endocr. Rev. 17:156-186.
14. Cronier L, Guibourdenche J, Niger C, Malassine A. 1999. Oestradiol stimulates morphological and functional differentiation of human villous cytotrophoblast. Placenta 20:669-676.
15. Kumar P, Kamat A, Mendelson CR. 2009. Estrogen receptor α (ERα) mediates stimulatory effects of estrogen on aromatase (CYP19) gene expression in human placenta. Mol. Endocrinol. 23:784-793.
16. Kumar P, Mendelson CR. 2011. Estrogen-related receptor γ (ERRγ) mediates oxygen-dependent induction of aromatase (CYP19) gene expression during human trophoblast differentiation. Mol. Endocrinol. 25: 1513-1526.
17. Anson-Cartwright L, Dawson K, Holmyard D, Fisher SJ, Lazzarini RA, Cross JC. 2000. The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta. Nat. Genet. 25:311-314.
18. Schreiber J, Riethmacher-Sonnenberg E, Riethmacher D, Tuerk EE, Enderich J, Bosl MR, Wegner M. 2000. Placental failure in mice lacking the mammalian homolog of glial cells missing, GCMa. Mol. Cell. Biol. 20:2466-2474.
19. Yu C, Shen K, Lin M, Chen P, Lin C, Chang GD, Chen H. 2002. GCMa regulates the syncytin-mediated trophoblastic fusion. J. Biol. Chem. 277: 50062-50068.
20. Chang M, Mukherjea D, Gobble RM, Groesch KA, Torry RJ, Torry DS. 2008. Glial cell missing 1 regulates placental growth factor (PGF) gene transcription in human trophoblast. Biol. Reprod. 78:841-851.
21. Yamada K, Ogawa H, Honda S, Harada N, Okazaki T. 1999. A GCM motif protein is involved in placenta-specific expression of human aromatase gene. J. Biol. Chem. 274:32279-32286.
22. Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
23. Bartel DP. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136:215-233.
24. van Rooij E, Liu N, Olson EN. 2008. MicroRNAs flex their muscles. Trends Genet. 24:159-166.
25. Turner ML, Schnorfeil FM, Brocker T. 2011. MicroRNAs regulate dendritic cell differentiation and function. J. Immunol. 187:3911-3917.
26. Braun T, Gautel M. 2011. Transcriptional mechanisms regulating skeletal muscle differentiation, growth and homeostasis. Nat. Rev. Mol. Cell Biol. 12:349-361.
27. Garzon R, Calin GA, Croce CM. 2009. MicroRNAs in cancer. Annu. Rev. Med. 60:167-179.
28. Mendell JT. 2008. miRiad roles for the miR-17-92 cluster in development and disease. Cell 133:217-222.
29. Hawkins SM, Buchold GM, Matzuk MM. 2011. Minireview: the roles of small RNA pathways in reproductive medicine. Mol. Endocrinol. 25: 1257-1279.
30. Renthal NE, Chen CC, Williams KC, Gerard RD, Prange-Kiel J, Mendelson CR. 2010. miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor. Proc. Natl. Acad. Sci. U. S. A. 107:20828-20833.
31. Williams KC, Renthal NE, Condon JC, Gerard RD, Mendelson CR. 2012. MicroRNA-200a serves a key role in the decline of progesterone receptor function leading to term and preterm labor. Proc. Natl. Acad. Sci. U. S. A. 109:7529-7534.
32. Jiang B, Mendelson CR. 2006. Adenoviral-mediated gene delivery to rophoblast cells. Methods Mol. Med. 121:451-461.
33. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
34. Moffat J, Grueneberg DA, Yang X, Kim SY, Kloepfer AM, Hinkle G, Piqani B, Eisenhaure TM, Luo B, Grenier JK, Carpenter AE, Foo SY, Stewart SA, Stockwell BR, Hacohen N, Hahn WC, Lander ES, Sabatini DM, Root DE. 2006. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124:1283-1298.
35. Hossain A, Kuo MT, Saunders GF. 2006. MiR-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol. Cell. Biol. 26:8191-8201.
36. Castellano L, Giamas G, Jacob J, Coombes RC, Lucchesi W, Thiruchelvam P, Barton G, Jiao LR, Wait R, Waxman J, Hannon GJ, Stebbing J. 2009. The estrogen receptor-α-induced microRNA signature regulates itself and its transcriptional response. Proc. Natl. Acad. Sci. U. S. A. 106: 15732-15737.
37. Eilers M, Eisenman RN. 2008. Myc's broad reach. Genes Dev. 22:2755-2766.
38. Rydnert J, Pfeifer-Ohlsson S, Goustin AS, Ohlsson R. 1987. Temporal and spatial pattern of cellular myc oncogene expression during human placental development. Placenta 8:339-345.
39. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. 2005. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843.
40. Olive V, Jiang I, He L. 2010. miR-17-92, a cluster of miRNAs in the midst of the cancer network. Int. J. Biochem. Cell Biol. 42:1348-1354.
41. Concepcion CP, Bonetti C, Ventura A. 2012. The microRNA-17-92 family of microRNA clusters in development and disease. Cancer J. 18: 262-267.
42. Conkrite K, Sundby M, Mukai S, Thomson JM, Mu D, Hammond SM, MacPherson D. 2011. miR-17 ̃92 cooperates with RB pathway mutations to promote retinoblastoma. Genes Dev. 25:1734-1745.
43. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y, Takahashi T. 2005. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 65:9628-9632.
44. Ota A, Tagawa H, Karnan S, Tsuzuki S, Karpas A, Kira S, Yoshida Y, Seto M. 2004. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res. 64:3087-3095.
45. Ivanovska I, Ball AS, Diaz RL, Magnus JF, Kibukawa M, Schelter JM, Kobayashi SV, Lim L, Burchard J, Jackson AL, Linsley PS, Cleary MA. 2008. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol. Cell. Biol. 28:2167-2174.
46. Mu P, Han YC, Betel D, Yao E, Squatrito M, Ogrodowski P, de Stanchina E, D'Andrea A, Sander C, Ventura A. 2009. Genetic dissection of the miR-17 ̃92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev. 23:2806-2811.
47. Zhou Y, Genbacev O, Fisher SJ. 2003. The human placenta remodels the uterus by using a combination of molecules that govern vasculogenesis or leukocyte extravasation. Ann. N. Y. Acad. Sci. 995:73-83.
48. Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D, Stone JR, Jaenisch R, Sharp PA, Jacks T. 2008. Targeted deletion reveals essential and overlapping functions of the miR-17 ̃92 family of miRNA clusters. Cell 132:875-886.
49. Lu Y, Thomson JM, Wong HY, Hammond SM, Hogan BL. 2007. Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev. Biol. 310:442-453.
50. Pospisil V, Vargova K, Kokavec J, Rybarova J, Savvulidi F, Jonasova A, Necas E, Zavadil J, Laslo P, Stopka T. 2011. Epigenetic silencing of the oncogenic miR-17-92 cluster during PU.1-directed macrophage differentiation. EMBO J. 30:4450-4464.
51. Foshay KM, Gallicano GI. 2009. miR-17 family miRNAs are expressed during early mammalian development and regulate stem cell differentiation. Dev. Biol. 326:431-443.
52. Loven J, Zinin N, Wahlstrom T, Muller I, Brodin P, Fredlund E, Ribacke U, Pivarcsi A, Pahlman S, Henriksson M. 2010. MYCNregulated microRNAs repress estrogen receptor-α (ESR1) expression and neuronal differentiation in human neuroblastoma. Proc. Natl. Acad. Sci. U. S. A. 107:1553-1558.
53. Chen X, Liu Z, Xu J. 2010. The cooperative function of nuclear receptor coactivator 1 (NCOA1) and NCOA3 in placental development and embryo survival. Mol. Endocrinol. 24:1917-1934.
54. Vervoorts J, Luscher-Firzlaff J, Luscher B. 2006. The ins and outs of MYC regulation by posttranslational mechanisms. J. Biol. Chem. 281: 34725-34729.
55. Dubois NC, Adolphe C, Ehninger A, Wang RA, Robertson EJ, Trumpp A. 2008. Placental rescue reveals a sole requirement for c-Myc in embryonic erythroblast survival and hematopoietic stem cell function. Development 135:2455-2465.
56. Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, Wentzel E, Furth EE, Lee WM, Enders GH, Mendell JT, Thomas-Tikhonenko A. 2006. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat. Genet. 38:1060-1065.
57. Redman CW, Sargent IL. 2005. Latest advances in understanding preeclampsia. Science 308:1592-1594.
58. Ness RB, Sibai BM. 2006. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am. J. Obstet. Gynecol. 195:40-49.
59. Pineles BL, Romero R, Montenegro D, Tarca AL, Han YM, Kim YM, Draghici S, Espinoza J, Kusanovic JP, Mittal P, Hassan SS, Kim CJ. 2007. Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am. J. Obstet. Gynecol. 196:261-266.
60. Lunell NO, Nylund LE, Lewander R, Sarby B. 1982. Uteroplacental blood flow in pre-eclampsia measurements with indium-113m and a computer-linked gamma camera. Clin. Exp. Hypertens. B 1:105-117.
61. Wang W, Feng L, Zhang H, Hachy S, Satohisa S, Laurent LC, Parast M, Zheng J, Chen DB. 2012. Preeclampsia up-regulates angiogenesisassociated microRNA (i.e., miR-17, -20a, and -20b) that target ephrin-B2 and EPHB4 in human placenta. J. Clin. Endocrinol. Metab. 97:E1051- E1059.
62. Red-Horse K, Kapidzic M, Zhou Y, Feng KT, Singh H, Fisher SJ. 2005. EPHB4 regulates chemokine-evoked trophoblast responses: a mechanism for incorporating the human placenta into the maternal circulation. Development 132:4097-4106.
63. Ishibashi O, Ohkuchi A, Ali MM, Kurashina R, Luo SS, Ishikawa T, Takizawa T, Hirashima C, Takahashi K, Migita M, Ishikawa G, Yoneyama K, Asakura H, Izumi A, Matsubara S, Takeshita T, Takizawa T. 2012. Hydroxysteroid (17-α) dehydrogenase 1 is dysregulated by miR- 210 and miR-518c that are aberrantly expressed in preeclamptic placentas: a novel marker for predicting preeclampsia. Hypertension 59:265-273.
64. Hertig A, Liere P, Chabbert-Buffet N, Fort J, Pianos A, Eychenne B, Cambourg A, Schumacher M, Berkane N, Lefevre G, Uzan S, Rondeau E, Rozenberg P, Rafestin-Oblin ME. 2010. Steroid profiling in preeclamptic women: evidence for aromatase deficiency. Am. J. Obstet. Gynecol. 203:477-479.
65. Shimodaira M, Nakayama T, Sato I, Sato N, Izawa N, Mizutani Y, Furuya K, Yamamoto T. 2012. Estrogen synthesis genes CYP19A1, HSD3B1, and HSD3B2 in hypertensive disorders of pregnancy. Endocrine 42:700-707.
66. Chen CP, Chen CY, Yang YC, Su TH, Chen H. 2004. Decreased placental GCM1 (glial cells missing) gene expression in pre-eclampsia. Placenta 25:413-421.
67. Bainbridge SA, Minhas A, Whiteley KJ, Qu D, Sled JG, Kingdom JC, Adamson SL. 2012. Effects of reduced Gcm1 expression on trophoblast morphology, fetoplacental vascularity, and pregnancy outcomes in mice. Hypertension 59:732-739.